Related Experiment Video
Updated: May 22, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host
Varun Sridhar1, Natarajan Rajagopalan, C Shivaprasad
1Internal Medicine Department, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India.
Abstract:
Infection from Aspergillus results in a wide range of diseases from simple Aspergillus pneumonia to fatal invasive Aspergillosis. Though the fungus is known to predominantly affect the immunocompromised host, it has also been known to cause acute pneumonia in immunocompetent hosts which is invariably fatal. It presents as an acute pneumonia with bilateral chest infiltrates on radiograph. Early clinical suspicion and microbiological identification by measures such as broncho alveolar lavage and initiation of therapy with voricanozole significantly increase the chances of survival. In this article the authors discuss a case of acute community acquired Aspergillus pneumonia in an immunocompetent host who survived due to early identification and prompt treatment with appropriate antifungal medication.
Insights
Acute Aspergillus pneumonia, though often fatal in healthy individuals, can be survived. Early diagnosis and voriconazole treatment are key to successful outcomes in these rare community-acquired fungal infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Aspergillus infections typically affect immunocompromised individuals.
- Invasive Aspergillosis and Aspergillus pneumonia can be severe, even fatal.
- Acute pneumonia caused by Aspergillus in immunocompetent hosts is rare and often lethal.
Observation:
- The case involved an immunocompetent host presenting with acute community-acquired Aspergillus pneumonia.
- Radiographs showed bilateral chest infiltrates, indicative of severe pneumonia.
- The patient's immunocompetent status made the diagnosis and prognosis challenging.
Findings:
- Early clinical suspicion was crucial for prompt diagnosis.
- Microbiological identification via bronchoalveolar lavage confirmed Aspergillus infection.
- Initiation of voriconazole therapy was critical for patient survival.
Implications:
- This case highlights the possibility of survival in immunocompetent patients with severe Aspergillus pneumonia.
- Emphasizes the importance of early recognition and aggressive antifungal treatment.
- Suggests voriconazole as a potentially life-saving therapy in such critical cases.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Atypical Pneumonia
Fungal Phylum Ascomycota
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia II: Pathophysiology